MONOCLONAL ANTIBODY NewsLatest News On MONOCLONAL ANTIBODY Monoclonal Antibody Dazukibart Shows Promise in Treating Dermatomyositis1/17/2025 2:08 AM Valaciclovir Shows Promise in Preventing Herpes Zoster During Anifrolumab Treatment for Lupus1/14/2025 7:50 AM Durvalumab Is Not Superior to Cetuximab in Head, Neck Cancer12/31/2024 8:19 AM Daratumumab Confirmed as SOC for AL Amyloidosis12/17/2024 6:55 AM Smoldering MM: Big Prevention Benefits With Daratumumab?12/16/2024 5:26 AM Self-Replicating mRNA Vaccine for COVID Prevention12/13/2024 12:43 PM Rituximab and Abatacept May Contribute to Cancer Risk in Patients With Rheumatoid Arthritis12/13/2024 6:15 AM Acalabrutinib Combo Promising as Frontline Treatment for CLL12/11/2024 5:10 AM Low-Dose Steroids Prevent GPA Relapse, With Caveats11/17/2024 4:37 PM Rituximab Not Inferior to Cyclophosphamide in Pediatric Vasculitis11/11/2024 5:26 AM Batoclimab Shows Rapid Effect on Key Graves’ Disease Markers11/4/2024 7:17 AM Bimekizumab Offers Durable and Consistent Benefits in HS11/4/2024 6:08 AM Myasthenia Gravis: Where Does Traditional Therapy Fit in?11/4/2024 3:52 AM Cendakimab That Targets IL-13 Shows Promise in Eosinophilic Esophagitis10/18/2024 4:57 AM First-in-Class B-Cell Depleting Agent Promising for Myasthenia Gravis10/17/2024 5:12 AM JAK Inhibitors, Biologics Show Nuanced Differences in Rheumatoid Arthritis Pain Outcomes10/17/2024 3:18 AM Sustained Control with Investigational Monoclonal Antibody for Myasthenia Gravis10/16/2024 5:14 PM FDA Approves Pfizer's Hympavzi for Hemophilia A, B10/11/2024 3:32 PM New Drug Class for Prurigo Nodularis Moving Forward10/7/2024 4:29 AM New Biologic Tulisokibart Beats Placebo in Ulcerative Colitis Trial10/2/2024 7:49 AM
